How do practitioners prescribe exercise to patients with breast cancer? Professional perspectives on the key considerations for aerobic exercise in patients with breast cancer undergoing chemotherapy.

Murray, J; Bennett, H; Perry, R; Bezak, E; Davison, K

How do practitioners prescribe exercise to patients with breast cancer? Professional perspectives on the key considerations for aerobic exercise in patients with breast cancer undergoing chemotherapy.

Murray, J

Bennett, H Perry, R Bezak, E Davison, K

Permalink

Publisher:: ELSEVIER SCI LTD
Publication Type:: Journal Article
Citation:: J Sci Med Sport, 2023, 26, (12), pp. 650-658
Issue Date:: 2023-12

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.05 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Murray, J https://orcid.org/0000-0002-9585-4951
dc.contributor.author	Bennett, H
dc.contributor.author	Perry, R
dc.contributor.author	Bezak, E
dc.contributor.author	Davison, K
dc.date.accessioned	2024-06-19T22:03:16Z
dc.date.available	2023-09-25
dc.date.available	2024-06-19T22:03:16Z
dc.date.issued	2023-12
dc.identifier.citation	J Sci Med Sport, 2023, 26, (12), pp. 650-658
dc.identifier.issn	1440-2440
dc.identifier.issn	1878-1861
dc.identifier.uri	http://hdl.handle.net/10453/179580
dc.description.abstract	OBJECTIVES: This study aimed to understand the key factors experienced accredited exercise physiologists (AEPs) and medical professionals consider when prescribing/recommending aerobic exercise to patients with breast cancer undergoing chemotherapy. DESIGN: Modified Delphi Survey. METHODS: A four-round, two-phase survey was conducted. Following a Delphi approach, four cancer-specific AEPs, four oncologists, and one breast cancer surgeon (median 13-yr breast-cancer-specific experience) completed phase one. Eighty-four AEPs (median 5-yr experience) completed phase two. Phase one participants answered open- and close-ended questions regarding key considerations for aerobic exercise in patients with breast cancer undergoing chemotherapy, and what information should be collected to guide exercise prescription. All questions and considerations agreed upon in phase one (>70 % rating 7-9 on a 0-9 Likert Scale) were rated by AEPs in phase two. RESULTS: Key considerations for exercise assessment and prescription aligned closely with exercise guidelines for cancer survivors. Common strategies for exercise individualisation were identified by AEPs, including separating aerobic exercise into 5-to--9-minute bouts when required and avoiding exercising to complete exhaustion. Exercise intensity and duration should be adjusted throughout chemotherapy to improve tolerance and adherence. Novel considerations for subjective questioning and objective assessments to tailor exercise prescription were outlined. CONCLUSIONS: This study identifies how professionals approach exercise assessment and prescription in patients with breast cancer undergoing chemotherapy. Findings can guide AEPs in practice when prescribing tailored exercise to breast cancer patients undergoing chemotherapy and inform future guidelines.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER SCI LTD
dc.relation.ispartof	J Sci Med Sport
dc.relation.isbasedon	10.1016/j.jsams.2023.09.018
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1106 Human Movement and Sports Sciences, 1116 Medical Physiology, 1117 Public Health and Health Services
dc.subject.classification	Sport Sciences
dc.subject.classification	3202 Clinical sciences
dc.subject.classification	4207 Sports science and exercise
dc.subject.classification	5201 Applied and developmental psychology
dc.subject.mesh	Humans
dc.subject.mesh	Female
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	Exercise
dc.subject.mesh	Exercise Therapy
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Humans
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	Exercise
dc.subject.mesh	Exercise Therapy
dc.subject.mesh	Female
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Cancer Survivors
dc.title	How do practitioners prescribe exercise to patients with breast cancer? Professional perspectives on the key considerations for aerobic exercise in patients with breast cancer undergoing chemotherapy.
dc.type	Journal Article
utslib.citation.volume	26
utslib.location.activity	Australia
utslib.for	1106 Human Movement and Sports Sciences
utslib.for	1116 Medical Physiology
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2024-06-19T22:03:14Z
pubs.issue	12
pubs.publication-status	Published
pubs.volume	26
utslib.citation.issue	12

Abstract:

OBJECTIVES: This study aimed to understand the key factors experienced accredited exercise physiologists (AEPs) and medical professionals consider when prescribing/recommending aerobic exercise to patients with breast cancer undergoing chemotherapy. DESIGN: Modified Delphi Survey. METHODS: A four-round, two-phase survey was conducted. Following a Delphi approach, four cancer-specific AEPs, four oncologists, and one breast cancer surgeon (median 13-yr breast-cancer-specific experience) completed phase one. Eighty-four AEPs (median 5-yr experience) completed phase two. Phase one participants answered open- and close-ended questions regarding key considerations for aerobic exercise in patients with breast cancer undergoing chemotherapy, and what information should be collected to guide exercise prescription. All questions and considerations agreed upon in phase one (>70 % rating 7-9 on a 0-9 Likert Scale) were rated by AEPs in phase two. RESULTS: Key considerations for exercise assessment and prescription aligned closely with exercise guidelines for cancer survivors. Common strategies for exercise individualisation were identified by AEPs, including separating aerobic exercise into 5-to--9-minute bouts when required and avoiding exercising to complete exhaustion. Exercise intensity and duration should be adjusted throughout chemotherapy to improve tolerance and adherence. Novel considerations for subjective questioning and objective assessments to tailor exercise prescription were outlined. CONCLUSIONS: This study identifies how professionals approach exercise assessment and prescription in patients with breast cancer undergoing chemotherapy. Findings can guide AEPs in practice when prescribing tailored exercise to breast cancer patients undergoing chemotherapy and inform future guidelines.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/179580